177 related articles for article (PubMed ID: 27431203)
1. Biochemical composition of malignant ascites determines high aggressiveness of undifferentiated ovarian tumors.
Mikuła-Pietrasik J; Uruski P; Szubert S; Moszyński R; Szpurek D; Sajdak S; Tykarski A; Książek K
Med Oncol; 2016 Aug; 33(8):94. PubMed ID: 27431203
[TBL] [Abstract][Full Text] [Related]
2. Ovarian cancer-derived ascitic fluids induce a senescence-dependent pro-cancerogenic phenotype in normal peritoneal mesothelial cells.
Mikuła-Pietrasik J; Uruski P; Matuszkiewicz K; Szubert S; Moszyński R; Szpurek D; Sajdak S; Tykarski A; Książek K
Cell Oncol (Dordr); 2016 Oct; 39(5):473-481. PubMed ID: 27444787
[TBL] [Abstract][Full Text] [Related]
3. Malignant ascites determine the transmesothelial invasion of ovarian cancer cells.
Mikuła-Pietrasik J; Uruski P; Szubert S; Szpurek D; Sajdak S; Tykarski A; Książek K
Int J Biochem Cell Biol; 2017 Nov; 92():6-13. PubMed ID: 28888784
[TBL] [Abstract][Full Text] [Related]
4. The Proangiogenic Capabilities of Malignant Ascites Generated by Aggressive Ovarian Tumors.
Mikuła-Pietrasik J; Uruski P; Szubert S; Maksin K; Moszyński R; Szpurek D; Woźniak A; Sajdak S; Tykarski A; Książek K
Biomed Res Int; 2017; 2017():2592496. PubMed ID: 29085834
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
[TBL] [Abstract][Full Text] [Related]
6. Decreased IL-1 RA concentration in ascites is associated with a significant improvement in overall survival in ovarian cancer.
Mustea A; Pirvulescu C; Könsgen D; Braicu EI; Yuan S; Sun P; Lichtenegger W; Sehouli J
Cytokine; 2008 Apr; 42(1):77-84. PubMed ID: 18329282
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between interleukin-10 level in ascites of patients with primary ovarian epithelial carcinoma and immune defect in peritoneal cavity].
Zhou JW; Cheng Q; Xie X; Chen HZ; Ye DF; Lu WG
Ai Zheng; 2004 May; 23(5):573-6. PubMed ID: 15142457
[TBL] [Abstract][Full Text] [Related]
8. Proinflammatory and immunosuppressive serum, ascites and cyst fluid cytokines in patients with early and advanced ovarian cancer and benign ovarian tumors.
Nowak M; Glowacka E; Szpakowski M; Szyllo K; Malinowski A; Kulig A; Tchorzewski H; Wilczynski J
Neuro Endocrinol Lett; 2010; 31(3):375-83. PubMed ID: 20588232
[TBL] [Abstract][Full Text] [Related]
9. Cytokines in peritoneal fluid of ovarian neoplasms.
de Lima CA; Silva Rodrigues IS; Martins-Filho A; Côbo Micheli D; Martins Tavares-Murta B; Candido Murta EF; Simões Nomelini R
J Obstet Gynaecol; 2020 Apr; 40(3):401-405. PubMed ID: 31476946
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of vascular endothelial growth factor expression in ovarian cancer patients: a long-term follow-up.
Rudlowski C; Pickart AK; Fuhljahn C; Friepoertner T; Schlehe B; Biesterfeld S; Schroeder W
Int J Gynecol Cancer; 2006; 16 Suppl 1():183-9. PubMed ID: 16515588
[TBL] [Abstract][Full Text] [Related]
11. Copper content in ascitic fluid is associated with angiogenesis and progression in ovarian cancer.
Onuma T; Mizutani T; Fujita Y; Yamada S; Yoshida Y
J Trace Elem Med Biol; 2021 Dec; 68():126865. PubMed ID: 34601284
[TBL] [Abstract][Full Text] [Related]
12. Malignant Ascites Promote Adhesion of Ovarian Cancer Cells to Peritoneal Mesothelium and Fibroblasts.
Uruski P; Mikuła-Pietrasik J; Pakuła M; Budkiewicz S; Drzewiecki M; Gaiday AN; Wierzowiecka M; Naumowicz E; Moszyński R; Tykarski A; Książek K
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921783
[TBL] [Abstract][Full Text] [Related]
13. Ovarian cancer ascites enhance the migration of patient-derived peritoneal mesothelial cells via cMet pathway through HGF-dependent and -independent mechanisms.
Matte I; Lane D; Laplante C; Garde-Granger P; Rancourt C; Piché A
Int J Cancer; 2015 Jul; 137(2):289-98. PubMed ID: 25482018
[TBL] [Abstract][Full Text] [Related]
14. The Epithelial-Mesenchymal Transition Initiated by Malignant Ascites Underlies the Transmesothelial Invasion of Ovarian Cancer Cells.
Pakuła M; Mikuła-Pietrasik J; Witucka A; Kostka-Jeziorny K; Uruski P; Moszyński R; Naumowicz E; Sajdak S; Tykarski A; Książek K
Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30609691
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
Kraft A; Weindel K; Ochs A; Marth C; Zmija J; Schumacher P; Unger C; Marmé D; Gastl G
Cancer; 1999 Jan; 85(1):178-87. PubMed ID: 9921991
[TBL] [Abstract][Full Text] [Related]
16. Potential Significance of Peptidome in Human Ovarian Cancer for Patients With Ascites.
Huang X; Zhou J; Tang R; Han S; Zhou X
Int J Gynecol Cancer; 2018 Feb; 28(2):355-362. PubMed ID: 29240604
[TBL] [Abstract][Full Text] [Related]
17. Thrombomodulin, a receptor for the serine protease thrombin, is decreased in primary tumors and metastases but increased in ascitic fluids of patients with advanced ovarian cancer FIGO IIIc.
Wilhelm S; Schmitt M; Parkinson J; Kuhn W; Graeff H; Wilhelm OG
Int J Oncol; 1998 Oct; 13(4):645-51. PubMed ID: 9735390
[TBL] [Abstract][Full Text] [Related]
18. Senescent peritoneal mesothelium induces a pro-angiogenic phenotype in ovarian cancer cells in vitro and in a mouse xenograft model in vivo.
Mikuła-Pietrasik J; Sosińska P; Naumowicz E; Maksin K; Piotrowska H; Woźniak A; Szpurek D; Książek K
Clin Exp Metastasis; 2016 Jan; 33(1):15-27. PubMed ID: 26433963
[TBL] [Abstract][Full Text] [Related]
19. Normalization of the ovarian cancer microenvironment by SPARC.
Said N; Socha MJ; Olearczyk JJ; Elmarakby AA; Imig JD; Motamed K
Mol Cancer Res; 2007 Oct; 5(10):1015-30. PubMed ID: 17951402
[TBL] [Abstract][Full Text] [Related]
20. Minocycline inhibits malignant ascites of ovarian cancer through targeting multiple signaling pathways.
Pourgholami MH; Ataie-Kachoie P; Badar S; Morris DL
Gynecol Oncol; 2013 Apr; 129(1):113-9. PubMed ID: 23274564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]